Bicycle Therapeutics (BCYC) Net Cash Flow: 2018-2025
Historic Net Cash Flow for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to -$71.9 million.
- Bicycle Therapeutics' Net Cash Flow rose 0.44% to -$71.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$241.8 million, marking a year-over-year decrease of 176.42%. This contributed to the annual value of $353.8 million for FY2024, which is 89.73% up from last year.
- According to the latest figures from Q3 2025, Bicycle Therapeutics' Net Cash Flow is -$71.9 million, which was up 1.98% from -$73.3 million recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Net Cash Flow ranged from a high of $504.6 million in Q2 2024 and a low of -$87.0 million during Q1 2025.
- In the last 3 years, Bicycle Therapeutics' Net Cash Flow had a median value of -$47.0 million in 2023 and averaged $28.0 million.
- As far as peak fluctuations go, Bicycle Therapeutics' Net Cash Flow plummeted by 1,200.46% in 2022, and later spiked by 2,780.59% in 2023.
- Quarterly analysis of 5 years shows Bicycle Therapeutics' Net Cash Flow stood at $179.2 million in 2021, then plummeted by 114.44% to -$25.9 million in 2022, then slumped by 81.50% to -$47.0 million in 2023, then skyrocketed by 79.64% to -$9.6 million in 2024, then increased by 0.44% to -$71.9 million in 2025.
- Its Net Cash Flow stands at -$71.9 million for Q3 2025, versus -$73.3 million for Q2 2025 and -$87.0 million for Q1 2025.